← Eichor
Study identifier: NCT03823534 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

Condition: Bone Metastases · Lymphoma · Multiple Myeloma  ·  Sponsor: St. Louis University

PhasePhase 3
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Nationally, the opioid crisis has become a major epidemic with increasing mortality rates each year. Orthopedic surgeons routinely prescribe narcotics instead of NSAIDs for post-op pain control because of risk of delayed healing and nonunion due to NSAID use. Orthopedic oncology, however, has a unique subset of patients that undergo prophylactic placement of intramedullary femoral nails. Because no fracture is present, these patients do not rely on inflammatory healing factors, allowing for post-op NSAID use. This study sets out to determine the effect of post-op toradol use in addition to opioids compared to solely opioids in patients undergoing prophylactic nailing of the femur.

This description comes directly from the study's public registry record.

Talk to the study team

David Greenberg, MD  ·  314-617-3410  ·  david.greenberg@health.slu.edu

Allison Gruender, MSN  ·  314-617-3406  ·  allison.gruender@health.slu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Saint Louis UniversitySt Louis, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03823534